Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 173

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 173
---
 service on the board of directors and its committees.

<div align='center'>105</div>

We do not have a formal policy in place with regard to diversity in considering candidates for our board of directors, but the board of directors strives to nominate candidates with a variety of complementary skills so that, as a group, the board of directors will possess the appropriate talent, skills and expertise to oversee our business. Code of Business Conduct and Ethics We adopted a Code of Ethics (the “Code”), which applies to all of our directors and employees, including our principal executive officer and principal financial officer. The Code includes guidelines dealing with the ethical handling of conflicts of interest, compliance with federal and state laws, financial reporting, and our proprietary information. The Code also contains procedures for dealing with and reporting violations of the Code. The Code is disclosed, and any amendments thereto, or any waivers of its requirements will be disclosed, on our website at www.mustangbio.com. Policy Prohibiting Hedging and Speculative Trading Pursuant to our Insider Trading Policy, our officers, directors, and employees are prohibited from engaging in speculative trading, including hedging transactions or short sale transactions with respect to Company securities. Limitation on Liability and Indemnification Matters Our amended and restated certificate of incorporation, as amended, and our amended and restated bylaws each limit our directors’ liability and may indemnify our directors and officers to the fullest extent permitted under the General Corporation Law of the State of Delaware (the “DGCL”). The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability for:

| ● | any breach of the director’s duty of loyalty to us or our stockholders; |

| ● | any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |

| ● | any unlawful payment of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL; or |

| ● | any transaction from which the director derived an improper benefit. |

The DGCL and our amended and restated bylaws provide that we will, in certain situations, indemnify our directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. We have entered or intend to enter into indemnification agreements with each of our directors and officers. These indemnification agreements may require us, among other things, to indemnify our directors and officers for some expenses